Our Approach
We approach international collaboration in life sciences not as a question of opportunity, but of structure.
In complex, cross-border environments, the challenge is rarely access. It is alignment — between systems, standards, expectations, and decision-making frameworks.
Our role is to support that alignment before any connection is made.
A Governance-First Perspective
We work from a simple premise:
In high-stakes environments, connection without qualification introduces risk.
We focus on clarifying whether entry should occur, under what conditions, and through what structure.
This approach is particularly relevant in UK–China life sciences collaboration, where regulatory, clinical, and institutional contexts differ in ways that are not always immediately visible.
Core Principles
These principles guide how we structure engagement before any collaboration begins:
Qualification Before Connection
We prioritise readiness, fit, and pathway clarity before facilitating any form of engagement.
Structure Before Scale
We design small, contained pathways that allow for validation, interpretation, and adjustment before expansion.
Decision Before Execution
We support informed decision-making at each stage, recognising that not all pathways should proceed.
What This Means in Practice
In practice, this approach involves:
- Clarifying whether a product or proposition can be understood and evaluated within the UK system.
- Assessing whether organisational, regulatory, and data foundations can withstand local scrutiny.
- Structuring pathways that allow for continuation, adjustment, or exit at defined points.
This is not about accelerating activity, but about enabling decisions.
Our Role
Our role remains upstream — in qualification, structure design, and decision support.
We do not operate as a brokerage or resource-matching layer.
We do not facilitate connections for their own sake.
We do not position ourselves within downstream delivery or execution.
How This Approach Applies in Practice
The following reflection illustrates how this approach is applied in the context of international market entry, particularly in relation to UK–China life sciences collaboration.
Rethinking the UK: From Market to Validation & Connection Node
Positioning the UK in Cross-System Work
The UK is not simply another market within a global sequence.
Its value lies in its ability to support validation, interpretation, and connection across systems.
Recognising this requires a shift from asking “where to go next” to asking:
What needs to be understood before moving forward?
Disclaimer
This page reflects the working perspectives of the EFEC UK–China Life Sciences Innovation Hub and is intended to support informed discussion. It does not constitute advice or represent the official positions of any affiliated organisations or partners.